VTE Prophylaxis After Traumatic Hip Fracture Surgery

Rationale for LMWH Prophylaxis

The American Academy of Orthopaedic Surgeons recommends that hip fracture patients receive VTE prophylaxis as they are at high risk for thromboembolism (strong strength of evidence, strong strength recommendation) 1
For patients with hip fractures, VTE prophylaxis should be continued for at least 28-35 days post-operatively 2, 3
Low-molecular-weight heparin (LMWH) is preferred for orthopedic surgery patients with the first dose given at least 12 hours from the time of surgery 3
For orthopedic surgery patients, enoxaparin 30 mg twice daily is the recommended dosing regimen 4, 5

A minimum duration of 10-14 days of thromboprophylaxis is recommended for orthopedic surgery patients, with consideration of up to 35 days for patients at higher risk for VTE (grade 2B) 3, 6
The American Academy of Orthopaedic Surgeons guideline specifically mentions administering Lovenox for 4 weeks (28 days) postoperatively in hip fracture patients 1

Lovenox 30 mg every 12 hours for 28 days aligns with current guidelines for hip fracture patients and provides appropriate duration and dosing for high-risk orthopedic patients 1, 2, 4, 5
Therapeutic warfarin for 28 days is not recommended as first-line prophylaxis for orthopedic surgery patients and has less predictable anticoagulation effect compared to LMWH 4, 5, 8

The American Academy of Orthopaedic Surgeons states that patients with no contraindications to LMWH (no history of bleeding disorders or medication allergies) can receive LMWH 1

Inadequate duration of prophylaxis is a common error in VTE prevention after hip fracture surgery and mechanical prophylaxis alone is insufficient for hip fracture patients unless there are contraindications to pharmacological prophylaxis 3, 5